Louis P. Garrison

Also affiliated with University of Washington

Economics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States”.

Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States

Value in Health(2019)10.1016/j.jval.2018.11.014

N/A

0.581DataRank · unranked

47 citations

Joseph Babigumira, Clément Tournier, Hans-Peter Goertz, Solomon J. Lubinga, Edith A. Perez +1 more

Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations

Pain(2020)10.1097/j.pain.0000000000001952

N/A

0DataRank · unranked

184 citations

Robert H. Dworkin, Dennis C. Turk, Michael P. McDermott, Christopher Eccleston, John T. Farrar +32 more

Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100355

N/A

0DataRank · unranked

17 citations

Joseph B. Babigumira, Eva A. Enns, David Stauffer, Robert W. Shafer, Ingrid A. Beck +5 more

Assessing the potential cost-effectiveness of the addition of atezolizumab to first-line platinum chemotherapy in advanced urothelial cancer: Implications for value-based pricing.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5031

N/A

0DataRank · unranked

1 citations

Leonidas Nikolaos Diamantopoulos, Marita Zimmerman, Louis P. Garrison, Petros Grivas, Ali Raza Khaki

Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.06.013

N/A

0DataRank · unranked

16 citations

Steven M. Devine, Louis P. Garrison, Irene Agodoa, Jack Badaracco, Matthew Gitlin +2 more